ATE206067T1 - Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe - Google Patents

Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe

Info

Publication number
ATE206067T1
ATE206067T1 AT97926146T AT97926146T ATE206067T1 AT E206067 T1 ATE206067 T1 AT E206067T1 AT 97926146 T AT97926146 T AT 97926146T AT 97926146 T AT97926146 T AT 97926146T AT E206067 T1 ATE206067 T1 AT E206067T1
Authority
AT
Austria
Prior art keywords
delivering
application
dense
particle
transdermal
Prior art date
Application number
AT97926146T
Other languages
English (en)
Inventor
David Francis Sarphie
Terry Lee Burkoth
Original Assignee
Powderject Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Res Ltd filed Critical Powderject Res Ltd
Application granted granted Critical
Publication of ATE206067T1 publication Critical patent/ATE206067T1/de

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/22Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by pressing in moulds or between rollers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/89Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
AT97926146T 1996-06-17 1997-06-17 Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe ATE206067T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9612629.7A GB9612629D0 (en) 1996-06-17 1996-06-17 Method for providing dense particle compositions for use in transdermal particle delivery
PCT/GB1997/001636 WO1997048485A1 (en) 1996-06-17 1997-06-17 Method for providing dense particle compositions for use in transdermal particle delivery

Publications (1)

Publication Number Publication Date
ATE206067T1 true ATE206067T1 (de) 2001-10-15

Family

ID=10795416

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97926146T ATE206067T1 (de) 1996-06-17 1997-06-17 Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe

Country Status (11)

Country Link
EP (1) EP0912239B1 (de)
JP (1) JP2000513338A (de)
AT (1) ATE206067T1 (de)
AU (1) AU3102597A (de)
CA (1) CA2258554C (de)
DE (1) DE69706988T2 (de)
DK (1) DK0912239T3 (de)
ES (1) ES2164348T3 (de)
GB (1) GB9612629D0 (de)
PT (1) PT912239E (de)
WO (1) WO1997048485A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7223739B1 (en) 1995-06-07 2007-05-29 Powderject Vaccines, Inc. Adjuvanted genetic vaccines
GB9619002D0 (en) * 1996-09-11 1996-10-23 Oxford Biosciences Ltd Particle delivery
GB9819272D0 (en) * 1998-09-03 1998-10-28 Andaris Ltd Microparticles
WO2000014547A1 (en) * 1998-09-04 2000-03-16 Powderject Research Limited Immunodiagnostics using particle delivery methods
IL142276A0 (en) * 1998-10-01 2002-03-10 Powderject Res Ltd Spray coated microparticles for use in needleless syringes
US6881723B1 (en) 1998-11-05 2005-04-19 Powderject Vaccines, Inc. Nucleic acid constructs
EP1148902A1 (de) * 1999-01-22 2001-10-31 PowderJect Research Limited Methode zur steigerung von nadelloser transdermaler medikamentenverabreichung in pulverform
KR100845769B1 (ko) 1999-02-03 2008-07-11 파우더젝트 리서치 리미티드 하이드로겔 입자 제제
AU3593200A (en) 1999-02-09 2000-08-29 Powderject Vaccines, Inc. (mycobacterium tuberculosis), immunization
EP1158961A1 (de) * 1999-03-08 2001-12-05 PowderJect Research Limited Verabreichung von mikroteilchen-formulierungen unter verwendung einer nadellosen spritze zur verzörgerten freigabe bioaktiver verbindungen
US6190701B1 (en) 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids
ATE285806T1 (de) 1999-10-11 2005-01-15 Felton International Inc Universelle antiinfektionsschutzvorrichtung für nadellose injektoren
US7196066B1 (en) 1999-11-03 2007-03-27 Powderject Vaccines, Inc. DNA-vaccines based on constructs derived from the genomes of human and animal pathogens
US7887506B1 (en) 1999-11-23 2011-02-15 Pulse Needlefree Systems, Inc. Safety mechanism to prevent accidental patient injection and methods of same
DK1379273T3 (da) 2000-11-27 2009-11-09 Powderject Vaccines Inc Nukleinsyreadjuvanser
GB0103620D0 (en) * 2001-02-14 2001-03-28 Prometic Biosciences Ltd Sterile composition and its preparation
WO2002101412A2 (en) 2001-06-08 2002-12-19 Powderject Vaccines, Inc. Spray freeze-dried compositions
IL152574A (en) * 2002-10-31 2009-09-22 Transpharma Medical Ltd A system for passing through the skin of dry items or dried medicines
US8133505B2 (en) 2002-10-31 2012-03-13 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US7383084B2 (en) 2002-10-31 2008-06-03 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized medications
US7662404B2 (en) 2002-10-31 2010-02-16 Transpharma Medical Ltd. Transdermal delivery system for dried particulate or lyophilized peptides and polypeptides
AU2007306936B2 (en) 2006-10-12 2014-02-06 The University Of Queensland Compositions and methods for modulating immune responses
HUE041957T2 (hu) 2006-12-01 2019-06-28 Novartis Ag Anti-P-szelektin antitestek és eljárások azok alkalmazására gyulladásos betegségek kezelésére
US20110212096A1 (en) 2006-12-01 2011-09-01 Scott Rollins Anti-p-selectin antibodies and methods of their use and identification
US8945565B2 (en) 2006-12-01 2015-02-03 Selexys Pharmaceuticals Corporation Methods of treating inflammatory or thrombotic conditions with anti-P-selectin antibodies
PL2712622T3 (pl) 2008-05-21 2017-01-31 Ferring B.V. Ulegająca rozpadowi w ustach desmopresyna do zwiększania początkowego okresu snu niezakłócanego przez nokturię
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
DE102009002826A1 (de) * 2009-05-05 2010-11-11 Beiersdorf Ag Nadelfreies Injektionssystem zur kosmetischen Wirkstoffapplikation
ES2362525B8 (es) 2009-10-08 2013-01-03 Azurebio, S.L. Formulación de medicamentos en forma de agujas percutaneas penetrantes.
US11311610B2 (en) 2010-11-01 2022-04-26 University Of Technology Sydney Immune-modulating agents and uses therefor
MX2014011488A (es) 2012-03-23 2015-05-11 Univ Queensland Agente inmunomodulador y usos para el mismo.
SG11201807106WA (en) * 2016-02-23 2018-09-27 Merck Patent Gmbh Glycine particles

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4018037A1 (de) * 1990-02-10 1991-08-14 Peroxid Chemie Gmbh Verfahren zur herstellung von peroxoborat-agglomeraten
US5147291A (en) * 1990-06-11 1992-09-15 Cukier A David Sound transmission apparatus for uniformly administering chemical composition through the skin

Also Published As

Publication number Publication date
CA2258554A1 (en) 1997-12-24
ES2164348T3 (es) 2002-02-16
AU3102597A (en) 1998-01-07
DK0912239T3 (da) 2001-11-19
EP0912239B1 (de) 2001-09-26
JP2000513338A (ja) 2000-10-10
DE69706988T2 (de) 2002-04-04
GB9612629D0 (en) 1996-08-21
EP0912239A1 (de) 1999-05-06
PT912239E (pt) 2002-03-28
CA2258554C (en) 2006-08-15
DE69706988D1 (de) 2001-10-31
WO1997048485A1 (en) 1997-12-24

Similar Documents

Publication Publication Date Title
ATE206067T1 (de) Verfahren zur lieferung von zusammensetzungen aus dichten teilchen zur anwendung in transdermale teilchen abgabe
EE9700176A (et) Kuivpulbriinhalaatorites kasutatav pulber, selle valmistamismeetod, selles kasutatavad osakesed ja meetod nende valmistamiseks ning pulbri lisandi kasutamine
ATE312600T1 (de) Verfahren und system zur behandlung dispergierbarer feiner pulver
ATE164060T1 (de) Inhalationspulver und verfahren zu ihrer herstellung
DE60030721D1 (de) Pulverpartikel mit glatter oberfläche zur verwendung in der inhalationstherapie
GEP20043258B (en) Systems and Methods for Aerosolizing Pharmaceutical Formulations
ATE152573T1 (de) Protein mit zeitverabreichung
NZ333844A (en) Compositions comprising mircoparticles of water-insoluble substances and method for preparing same
DE59109215D1 (de) Werkstoff als ausgangsmaterial zur herstellung von knochenzement, verfahren zu seiner herstellung, und verfahren zur herstellung von knochenzement
DE69717997D1 (de) Verfahren zur herstellung von trockenen pulverteilchen, pulver hergestellt durch dieses verfahren und eine elektrode und eine vorrichtung zur anwendung in diesem verfahren
PL360254A1 (en) Pharmaceutical compositions
ATE241958T1 (de) Mahlverfahren zur herstellung feingemahlener medizinischer substanzen
IL142276A0 (en) Spray coated microparticles for use in needleless syringes
HUP9802498A2 (hu) Eljárás és berendezés hatóanyagoknak valamely szűrőanyagra történő felhordására
DE69408122D1 (de) Zusammensetzung aus mikropartikeln in verdichteter phase und verfahren
IL115869A0 (en) Implantable device for the administration of active substances to plants and a process for the production thereof
YU48978B (sh) Postupak za dobijanje preparata koji sadrži trandolapril i verapamil
ATE498394T1 (de) Verfahren zur herstellung eines medikaments
Mobilization et al. Trends in Antibody Deal-Making & Financing

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee